We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

1,079 hedge funds and large institutions have $56.6B invested in Regeneron Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 175 funds opening new positions, 428 increasing their positions, 321 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 175 | Existing positions closed: 97

33% more repeat investments, than reductions

Existing positions increased: 428 | Existing positions reduced: 321

6% more funds holding

Funds holding: 1,017 → 1,079 (+62)

4% more capital invested

Capital invested by funds: $54.4B → $56.6B (+$2.25B)

0.66% less ownership

Funds ownership: 86.01% → 85.34% (-0.66%)

12% less funds holding in top 10

Funds holding in top 10: 17 → 15 (-2)

33% less call options, than puts

Call options by funds: $985M | Put options by funds: $1.48B

Holders
1,079
Holders Change
+62
Holders Change %
+6.1%
% of All Funds
16.61%
Holding in Top 10
15
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-11.76%
% of All Funds
0.23%
New
175
Increased
428
Reduced
321
Closed
97
Calls
$985M
Puts
$1.48B
Net Calls
-$492M
Net Calls Change
-$207M

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$301M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$239M
3
Two Sigma Investments
Two Sigma Investments
New York
+$196M
4
Dodge & Cox
Dodge & Cox
California
+$172M
5
BlackRock
BlackRock
New York
+$150M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$618M
2
Capital International Investors
Capital International Investors
California
-$532M
3
AIM
ARK Investment Management
Florida
-$218M
4
Fidelity International
Fidelity International
Bermuda
-$162M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$143M
Name Holding Trade Value Shares
Change 		Change in
Stake
RC
401
RegentAtlantic Capital
New Jersey
$2.39M +$7.99K +13 +0.3%
BF
402
BOK Financial
Oklahoma
$2.35M -$23.4K -38 -1%
SPIA
403
Steward Partners Investment Advisory
New York
$2.34M +$292K +475 +15%
Wealthfront Advisers
404
Wealthfront Advisers
California
$2.34M +$79.9K +130 +4%
AIP
405
Ameritas Investment Partners
Nebraska
$2.33M +$20.3K +33 +0.9%
HBCM
406
Heron Bay Capital Management
Michigan
$2.33M +$25.8K +42 +1%
HCCM
407
Hudson Canyon Capital Management
New York
$2.33M +$121K +196 +6%
MPAM
408
Murphy Pohlad Asset Management
Minnesota
$2.33M -$55.3K -90 -2%
PCM
409
Penserra Capital Management
California
$2.33M +$2.26M +3,682 New
Northwestern Mutual Wealth Management
410
Northwestern Mutual Wealth Management
Wisconsin
$2.31M -$103K -167 -4%
Federated Hermes
411
Federated Hermes
Pennsylvania
$2.31M +$141K +230 +7%
HCM
412
Hudson Capital Management
New Jersey
$2.29M -$49.8K -81 -2%
HI
413
Horizon Investments
North Carolina
$2.28M +$789K +1,283 +55%
MML Investors Services
414
MML Investors Services
Massachusetts
$2.28M +$353K +574 +19%
MCC
415
Malaga Cove Capital
California
$2.27M -$44.3K -72 -2%
SAM
416
Shikiar Asset Management
New York
$2.26M -$211K -343 -9%
FTDI
417
First Trust Direct Indexing
Massachusetts
$2.26M -$51.6K -84 -2%
OA
418
Oak Associates
Ohio
$2.26M – – –
FA
419
FDx Advisors
Illinois
$2.23M +$1.11M +1,807 +105%
PWM
420
Perigon Wealth Management
California
$2.22M +$7.99K +13 +0.4%
WIS
421
Wright Investors Service
Connecticut
$2.22M +$67.6K +110 +3%
GCWM
422
Graham Capital Wealth Management
District of Columbia
$2.2M +$2.1M +3,412 New
NFG
423
Next Financial Group
Texas
$2.2M +$619K +1,006 +41%
WG
424
Winton Group
United Kingdom
$2.18M +$265K +431 +14%
DCM
425
Dupont Capital Management
Delaware
$2.17M -$374K -609 -15%
15 16
17
18 19

REGN Hedge Fund Activity: Q4 2021 in Review

1,079 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q4 2021, worth a combined $56.6B — up 4.1% from $54.4B a quarter earlier.

Buyers outnumbered sellers: 175 funds opened new REGN positions and 97 closed out — a net gain of 78 holders — while 428 added to existing stakes and 321 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $301M. The largest seller was Fidelity Investments, cutting an estimated $618M.

  • 1,079 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q4 2021, up from 1,017 in Q3 2021.
  • Funds reported $56.6B of Regeneron Pharmaceuticals stock for Q4 2021, up 4.1% quarter-over-quarter.
  • 175 funds opened new Regeneron Pharmaceuticals positions in Q4 2021 and 97 closed out, a net change of +78 holders.
  • The largest Regeneron Pharmaceuticals buyer in Q4 2021 was JP Morgan Chase, an estimated $301M added.
  • The largest Regeneron Pharmaceuticals seller in Q4 2021 was Fidelity Investments, an estimated $618M sold.

Based on aggregated 13F filings for Q4 2021.